Fangzhou LU
Dr. Fangzhou LU
Finance
Assistant Professor

3910 2533

KK 1019

Academic & Professional Qualification

  • PhD., MS., Massachusetts Institute of Technology
  • BS., New York University

Biography

Dr. Fangzhou Lu joined The University of Hong Kong (HKU) as an assistant professor at the HKU Business School in 2020. He received his Bachelor of Science from New York University, Stern School of Business in 2014, and Ph.D. from Massachusetts Institute of Technology (MIT) in 2020.

His research interests are Fintech, Cryptocurrency, Behavioral Finance, Entrepreneurial Finance, Emerging Markets, and Household Finance. His research is forthcoming in academic journals such as the Journal of Financial Economics. His recent research focus on economic growth following the COVID-19.

Research Interest

  • Fintech
  • Cryptocurrency
  • Behavioral Finance
  • International Finance

Selected Publications

  • “The Real Value of China’s Stock Market”, with Jennifer N. Carpenter and Robert F. Whitelaw, 2021, Journal of Financial Economics, 139(3), 679-696.

Recent Publications

Climbing the digital ladder

While Hong Kong may have all the financial credentials to be a cryptocurrency hub, industry experts doubt that digital currencies will become popular, and warn that novice investors could get hurt. Zeng Xinlan reports.

The Real Value of China’s Stock Market

What capital allocation role can China’s stock market play? Counter to perception, stock prices in China have become as informative about future profits as they are in the US. This rise in stock price informativeness has coincided with an increase in investment efficiency among privately owned firms, suggesting the market is aggregating information and providing useful signals to managers. However, price informativeness and investment efficiency for state-owned enterprises fell below that of privately owned firms after the postcrisis stimulus, perhaps reflecting unpredictable subsidies and state-directed investment policy. Finally, evidence from realized returns suggests Chinese firms face a higher cost of equity capital than US firms.